Therapeutic potential of cannabis, cannabidiol, and cannabinoid-based pharmaceuticals

CA Legare, WM Raup-Konsavage, KE Vrana - Pharmacology, 2022 - karger.com
Background: There is a growing interest in the use of cannabis (and its extracts), as well as
CBD oil (hemp extracts containing cannabidiol), for therapeutic purposes. While there is …

Alleviation of opioid withdrawal by cannabis and delta-9-tetrahydrocannabinol: A systematic review of observational and experimental human studies

JP De Aquino, A Bahji, O Gómez, M Sofuoglu - Drug and alcohol …, 2022 - Elsevier
Background While six US states have already officially authorized cannabinoids to substitute
opioids and treat opioid use disorder, the therapeutic benefits of cannabinoids remain …

“I got a bunch of weed to help me through the withdrawals”: Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums

MC Meacham, AL Nobles, DA Tompkins, J Thrul - PloS one, 2022 - journals.plos.org
A growing body of research has reported on the potential opioid-sparing effects of cannabis
and cannabinoids, but less is known about specific mechanisms. The present research …

Endogenous opiates and behavior: 2021

RJ Bodnar - Peptides, 2023 - Elsevier
This paper is the forty-fourth consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study

A Hillmer, C Chawar, A Lamri, J Hudson, F Kapczinski… - Plos one, 2023 - journals.plos.org
Background Individuals with an Opioid Use Disorder (OUD) have increased rates of
cannabis use in comparison to the general population. Research on the short-and long-term …

Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances

F Castillo, MC Hu, Y Liu, RR Balise, RD Weiss… - Drug and alcohol …, 2023 - Elsevier
Objective Patients in treatment with medications for opioid use disorder (MOUD) often report
use of other substances in addition to opioids. Few studies exist that examine the …

The prevalence and pattern of cannabis use among patients attending a methadone treatment clinic in Nairobi, Kenya

EW Ngarachu, SK Kiburi, FR Owiti… - … treatment, prevention, and …, 2022 - Springer
Background Cannabis use during methadone treatment may negatively impact treatment
outcomes. The aim of this study was to determine the prevalence and pattern of cannabis …

Evaluating associations between cannabis and heroin use

M Olfson - American journal of psychiatry, 2024 - Am Psychiatric Assoc
Despite being illegal under US federal law, cannabis has gained widespread public
acceptance. Over half of US adults (59%) believe that cannabis should be legal for …

“Everything is kind of the same except my mind is with me”: exploring cannabis substitution in a sample of adults in early recovery from an opioid or stimulant addiction

CA Beaugard, AY Walley, M Amodeo - Harm Reduction Journal, 2024 - Springer
Recovery from addiction is frequently equated with abstinence. However, some individuals
who resolve an addiction continue to use substances, including via substitution (ie …

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data

L Naji, T Rosic, N Sanger, B Dennis, A Hillmer… - Frontiers in …, 2022 - frontiersin.org
Importance It is known that only minority of patients with opioid use disorder (OUD) receive
treatment, of which only a fraction successfully complete treatment as intended. Factors …